Imolopesim

Dimeticone and Loperamide Hydrochloride, the active ingredients in Imolopesim, are an antifoaming agent and an opioid receptor agonist presented as an oral formulation for use in adults and children with diarrhea and related abdominal discomfort. They work together to reduce intestinal motility and decrease gas bubble surface tension, helping to control loose stools and bloating.

GNH USA supplies Imolopesim as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Imolopesim is an antidiarrheal medication that acts on intestinal motility and gas formation. - Diarrhea: reduces stool frequency and improves consistency in acute and chronic cases. - Acute gastroenteritis: alleviates loose‑stool symptoms caused by infectious gastroenteritis. - Traveler's diarrhea: provides symptomatic relief for short‑term travel‑related loose stools.

Common Side Effects: - Constipation: reduced bowel movements leading to hard stools. - Nausea: mild stomach upset after ingestion. - Abdominal cramps: occasional discomfort or cramping. - Flatulence: transient increase in gas. - Dizziness: light‑headed sensation. - Dry mouth: reduced salivation.

Serious or Rare Side Effects: - Severe constipation or bowel obstruction: risk of impaction requiring medical attention. - Toxic megacolon: rare but life‑threatening colonic dilation. - Allergic reactions: rash, itching, swelling, or anaphylaxis. - Cardiac arrhythmias: QT prolongation especially with interacting drugs. - Hepatotoxicity: elevated liver enzymes in susceptible individuals.

Before using Imolopesim, consider the following precautions: - Assess hydration status: ensure adequate fluid replacement in patients with active diarrhea. - Avoid in bacterial enterocolitis: do not use when infection with invasive bacteria is suspected. - Hypersensitivity: discontinue if allergic reactions such as rash or swelling occur. - Hepatic impairment: use with caution in patients with liver disease due to altered metabolism. - Monitor for constipation: watch for signs of severe constipation or abdominal distension. - Store at room temperature: keep in the original packaging, protect from moisture and direct sunlight.

Imolopesim may interact with other medicines; review the following: Major Interactions (Avoid): - CYP3A4 inhibitors (e.g., ketoconazole, erythromycin): increase loperamide plasma levels. - P‑glycoprotein inhibitors (e.g., quinidine, verapamil): raise risk of central opioid effects. - Other antidiarrheals: additive reduction of gut motility. - QT‑prolonging agents (e.g., macrolide antibiotics): heighten cardiac risk. Moderate Interactions (Monitor Closely): - Opioid analgesics: may enhance opioid‑related side effects. - Anticholinergic drugs: could worsen constipation. - Antispasmodics: may increase gastrointestinal slowdown. - Certain antidepressants (e.g., SSRIs): monitor for serotonin syndrome when combined with high‑dose loperamide.